神经科

订阅

MedSci主页 / 所有栏目 / 神经科

中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2010

2012-04-27 中华医学会神经病学分会脑血管病学组 中华神经科杂志

指南脑缺血
关注

中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2010.pdf 由于缺血性脑卒中和TIA患者有着不同的病因、病理生理机制、血管损伤的部位及不同的危险因素，且患者的依从性不同，决定了患者脑卒中再发的风险也有所差别。因而，从二级预防的角度看，对脑卒中患者进行科学的危险分层尤为重要，比如，采用Essen脑卒中危险评分或ABCD2评分法。 此指南适用于神经内科、内科和其他相关科室的医生，目的是为临床医

中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2010.pdf

由于缺血性脑卒中和TIA患者有着不同的病因、病理生理机制、血管损伤的部位及不同的危险因素，且患者的依从性不同，决定了患者脑卒中再发的风险也有所差别。因而，从二级预防的角度看，对脑卒中患者进行科学的危险分层尤为重要，比如，采用Essen脑卒中危险评分或ABCD2评分法。

此指南适用于神经内科、内科和其他相关科室的医生，目的是为临床医师提供参考，并不能用来代替临床思考。

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1800792, encodeId=8a071800e925e, content=<a href='/topic/show?id=8a3be319614' target=_blank style='color:#2F92EE;'>#短暂性脑缺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73196, encryptionId=8a3be319614, topicName=短暂性脑缺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c94141, createdName=liuquanmn, createdTime=Sat Oct 06 08:16:00 CST 2012, time=2012-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806979, encodeId=ed6118069e99a, content=<a href='/topic/show?id=245de9378aa' target=_blank style='color:#2F92EE;'>#缺血性脑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79378, encryptionId=245de9378aa, topicName=缺血性脑)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLGtr9t89oicQdQSIeKmOQic1weIWfibJ7H24XnT8ic9wiaUMTnXByenuwicOj8Jib42ibHXNptnuiaKthhiaVw/132, createdBy=ac342500190, createdName=ms7524819409032184, createdTime=Mon Mar 25 10:16:00 CST 2013, time=2013-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764482, encodeId=95701e64482a9, content=<a href='/topic/show?id=1612e319263' target=_blank style='color:#2F92EE;'>#短暂性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73192, encryptionId=1612e319263, topicName=短暂性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b6237741961, createdName=12498ca5m95暂无昵称, createdTime=Wed Jun 06 05:16:00 CST 2012, time=2012-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892557, encodeId=7f63189255e9e, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Mar 20 03:16:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289152, encodeId=a147128915266, content=<a href='/topic/show?id=cd268500578' target=_blank style='color:#2F92EE;'>#脑缺血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85005, encryptionId=cd268500578, topicName=脑缺血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=845e216, createdName=cqlidoudou, createdTime=Sun Apr 29 05:16:00 CST 2012, time=2012-04-29, status=1, ipAttribution=)]
    2012-10-06 liuquanmn

    #短暂性脑缺#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1800792, encodeId=8a071800e925e, content=<a href='/topic/show?id=8a3be319614' target=_blank style='color:#2F92EE;'>#短暂性脑缺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73196, encryptionId=8a3be319614, topicName=短暂性脑缺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c94141, createdName=liuquanmn, createdTime=Sat Oct 06 08:16:00 CST 2012, time=2012-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806979, encodeId=ed6118069e99a, content=<a href='/topic/show?id=245de9378aa' target=_blank style='color:#2F92EE;'>#缺血性脑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79378, encryptionId=245de9378aa, topicName=缺血性脑)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLGtr9t89oicQdQSIeKmOQic1weIWfibJ7H24XnT8ic9wiaUMTnXByenuwicOj8Jib42ibHXNptnuiaKthhiaVw/132, createdBy=ac342500190, createdName=ms7524819409032184, createdTime=Mon Mar 25 10:16:00 CST 2013, time=2013-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764482, encodeId=95701e64482a9, content=<a href='/topic/show?id=1612e319263' target=_blank style='color:#2F92EE;'>#短暂性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73192, encryptionId=1612e319263, topicName=短暂性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b6237741961, createdName=12498ca5m95暂无昵称, createdTime=Wed Jun 06 05:16:00 CST 2012, time=2012-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892557, encodeId=7f63189255e9e, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Mar 20 03:16:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289152, encodeId=a147128915266, content=<a href='/topic/show?id=cd268500578' target=_blank style='color:#2F92EE;'>#脑缺血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85005, encryptionId=cd268500578, topicName=脑缺血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=845e216, createdName=cqlidoudou, createdTime=Sun Apr 29 05:16:00 CST 2012, time=2012-04-29, status=1, ipAttribution=)]
    2013-03-25 ms7524819409032184

    #缺血性脑#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1800792, encodeId=8a071800e925e, content=<a href='/topic/show?id=8a3be319614' target=_blank style='color:#2F92EE;'>#短暂性脑缺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73196, encryptionId=8a3be319614, topicName=短暂性脑缺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c94141, createdName=liuquanmn, createdTime=Sat Oct 06 08:16:00 CST 2012, time=2012-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806979, encodeId=ed6118069e99a, content=<a href='/topic/show?id=245de9378aa' target=_blank style='color:#2F92EE;'>#缺血性脑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79378, encryptionId=245de9378aa, topicName=缺血性脑)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLGtr9t89oicQdQSIeKmOQic1weIWfibJ7H24XnT8ic9wiaUMTnXByenuwicOj8Jib42ibHXNptnuiaKthhiaVw/132, createdBy=ac342500190, createdName=ms7524819409032184, createdTime=Mon Mar 25 10:16:00 CST 2013, time=2013-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764482, encodeId=95701e64482a9, content=<a href='/topic/show?id=1612e319263' target=_blank style='color:#2F92EE;'>#短暂性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73192, encryptionId=1612e319263, topicName=短暂性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b6237741961, createdName=12498ca5m95暂无昵称, createdTime=Wed Jun 06 05:16:00 CST 2012, time=2012-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892557, encodeId=7f63189255e9e, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Mar 20 03:16:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289152, encodeId=a147128915266, content=<a href='/topic/show?id=cd268500578' target=_blank style='color:#2F92EE;'>#脑缺血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85005, encryptionId=cd268500578, topicName=脑缺血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=845e216, createdName=cqlidoudou, createdTime=Sun Apr 29 05:16:00 CST 2012, time=2012-04-29, status=1, ipAttribution=)]
    2012-06-06 12498ca5m95暂无昵称

    #短暂性#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1800792, encodeId=8a071800e925e, content=<a href='/topic/show?id=8a3be319614' target=_blank style='color:#2F92EE;'>#短暂性脑缺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73196, encryptionId=8a3be319614, topicName=短暂性脑缺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c94141, createdName=liuquanmn, createdTime=Sat Oct 06 08:16:00 CST 2012, time=2012-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806979, encodeId=ed6118069e99a, content=<a href='/topic/show?id=245de9378aa' target=_blank style='color:#2F92EE;'>#缺血性脑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79378, encryptionId=245de9378aa, topicName=缺血性脑)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLGtr9t89oicQdQSIeKmOQic1weIWfibJ7H24XnT8ic9wiaUMTnXByenuwicOj8Jib42ibHXNptnuiaKthhiaVw/132, createdBy=ac342500190, createdName=ms7524819409032184, createdTime=Mon Mar 25 10:16:00 CST 2013, time=2013-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764482, encodeId=95701e64482a9, content=<a href='/topic/show?id=1612e319263' target=_blank style='color:#2F92EE;'>#短暂性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73192, encryptionId=1612e319263, topicName=短暂性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b6237741961, createdName=12498ca5m95暂无昵称, createdTime=Wed Jun 06 05:16:00 CST 2012, time=2012-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892557, encodeId=7f63189255e9e, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Mar 20 03:16:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289152, encodeId=a147128915266, content=<a href='/topic/show?id=cd268500578' target=_blank style='color:#2F92EE;'>#脑缺血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85005, encryptionId=cd268500578, topicName=脑缺血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=845e216, createdName=cqlidoudou, createdTime=Sun Apr 29 05:16:00 CST 2012, time=2012-04-29, status=1, ipAttribution=)]
    2013-03-20 guihongzh

    #缺血性#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1800792, encodeId=8a071800e925e, content=<a href='/topic/show?id=8a3be319614' target=_blank style='color:#2F92EE;'>#短暂性脑缺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73196, encryptionId=8a3be319614, topicName=短暂性脑缺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c94141, createdName=liuquanmn, createdTime=Sat Oct 06 08:16:00 CST 2012, time=2012-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806979, encodeId=ed6118069e99a, content=<a href='/topic/show?id=245de9378aa' target=_blank style='color:#2F92EE;'>#缺血性脑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79378, encryptionId=245de9378aa, topicName=缺血性脑)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLGtr9t89oicQdQSIeKmOQic1weIWfibJ7H24XnT8ic9wiaUMTnXByenuwicOj8Jib42ibHXNptnuiaKthhiaVw/132, createdBy=ac342500190, createdName=ms7524819409032184, createdTime=Mon Mar 25 10:16:00 CST 2013, time=2013-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764482, encodeId=95701e64482a9, content=<a href='/topic/show?id=1612e319263' target=_blank style='color:#2F92EE;'>#短暂性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73192, encryptionId=1612e319263, topicName=短暂性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b6237741961, createdName=12498ca5m95暂无昵称, createdTime=Wed Jun 06 05:16:00 CST 2012, time=2012-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892557, encodeId=7f63189255e9e, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Mar 20 03:16:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289152, encodeId=a147128915266, content=<a href='/topic/show?id=cd268500578' target=_blank style='color:#2F92EE;'>#脑缺血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85005, encryptionId=cd268500578, topicName=脑缺血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=845e216, createdName=cqlidoudou, createdTime=Sun Apr 29 05:16:00 CST 2012, time=2012-04-29, status=1, ipAttribution=)]
    2012-04-29 cqlidoudou

    #脑缺血#

    0

相关资讯

ADA/EASD糖尿病高血糖管理声明

　　2型糖尿病的血糖管理已日趋复杂并伴随争议，随着可用药物的不断增多，有关药物潜在不良反应的担忧及强化血糖控制对于大血管并发症益处的不确定性不断增加。很多医生在为患者制定最佳策略时感到困惑。 　　为此，美国糖尿病学会（ADA）和欧洲糖尿病研究学会（EASD）召集了一个联合工作组，检验了证据并提出了非妊娠成人2型糖尿病患者降糖治疗的建议。ADA和EASD及其他学会和组织已经发布过几个相关的指南文件

2012中国“骨髓增生异常综合征诊疗共识”发布（附下载）

       骨髓增生异常综合征( MDS)是起源于造血干细胞的一组异质性髓系克隆性疾病，特点是髓系细胞发育异常，表现为无效造血、难治性血细胞减少、造血功能衰竭，高风险向急性髓系白血病(AML)转化。为规范临床诊治，中华医学会血液分会组织相关专家，讨论完成2012年《骨髓增生异常综合征诊断与治疗专家共识》，该共识发表在最新一期的《中华血液学杂志》上。 &n

ADA/EASD 2012年糖尿病指南解读和下载

　　美国糖尿病学会(ADA,American Diabetes Association)和欧洲糖尿病研究协会(EASD,European Association for the Study of Diabetes)发表有关2型糖尿病治疗的最新立场声明，强调以患者为中心的治疗。    　　新指南的主要建议： 　　? 必须根据患者具体特点制定个体化的血糖目标和降血糖治疗方

新指南勾画糖尿病管理地图:T2DM治疗步入患者为中心模式

　　ADA/EASD发布立场声明，强调T2DM治疗目标和策略应个体化 　　美国糖尿病学会(ADA)与欧洲糖尿病研究学会(EASD)联合发布关于2型糖尿病(T2DM)高血糖管理的立场声明，强调以患者为中心的个体化治疗，并提出降糖策略推荐意见(图1)。声明4月19日在线发表于《糖尿病护理》(Diabetes Care)。（查看指南） 　　T2DM血糖管理日趋复杂，其原因包括数量和种类增多的药物

2012AAN NSAID和其他补充剂防治成人发作性偏头痛循证指南

NSAIDs+and+other+complementary+treatments+for+episodic+migraine+prevention+in+adults.pdf 美国神经病学会和美国头痛学会在第64届美国神经病学会年会上发布了该指南。 指南制订专家组分析了1999年6月至2009年5月发表的有关研究。 结果显示，专家组回顾了284项研究摘要，最终共获得49项Ⅰ或Ⅱ类研究，其中

2012ADA/EASD立场声明-2型糖尿病患者的高血糖管理:以患者为中心的治疗

2012ADA+EASD立场声明-2型糖尿病患者的高血糖管理-以患者为中心的治疗.pdf 美国糖尿病学会(ADA)和欧洲糖尿病研究协会(EASD)联合发布立场声明，强调对2型糖尿病患者的高血糖进行个体化的治疗。这一最新指南于4月19日在线发表于Diabetes Care和Diabetologia。 新指南建议如下： 　　? 必须根据患者具体特点制定个体化的血糖目标和降血糖治疗方案;